Skip to main content
DIAMOND BIOFUND logo

DIAMOND BIOFUND — Investor Relations & Filings

Ticker · 6901 ISIN · TW0006901002 TW Financial and insurance activities
Open in API
Filings indexed 19 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country TW Taiwan
Listing TW 6901

About DIAMOND BIOFUND

http://www.diamondbiofund.com

Diamond Biofund Inc. is a professional venture capital firm dedicated to the life sciences and healthcare sectors. Established through a partnership between the Microbio Group and prominent financial institutions, the company operates as a large-scale evergreen fund focused on long-term industrial development. Its core strategy involves identifying and nurturing high-potential startups from the laboratory stage to market commercialization. The firm specializes in high-risk areas such as innovative drug discovery, advanced medical devices, and agricultural biotechnology. Beyond capital injection, Diamond Biofund provides strategic value-added services, including intellectual property management, clinical validation, and operational guidance. By integrating expertise in research, finance, and corporate management, the firm aims to build flagship enterprises and reduce the inherent risks of early-stage innovation.

Recent filings

Filing Released Lang Actions
115年04月內部人持股異動(事後)
Regulatory Filings Classification · 100% confidence The document text indicates an error message stating that the page cannot be accessed due to security reasons. There is no content related to any financial report, announcement, or filing. The text is very short (386 characters) and contains no information about company filings or financial data. Therefore, it does not fit any specific filing category and should be classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2026-05-05 Chinese
115年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, and major shareholders, with specific numbers of shares held and pledged shares. It is a disclosure of insider shareholdings and related information. There is no indication of financial results, management discussion, meeting materials, or legal proceedings. The document is a notification of insider shareholdings and changes, which corresponds to the category of Director's Dealing (DIRS), as it reports personal share transactions or holdings by company directors and executives. The document length is 2869 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report. Therefore, the most appropriate classification is DIRS with high confidence.
2026-05-05 Chinese
公告本公司投資部副總裁辭任
Board/Management Information Classification · 100% confidence The document is a short announcement about a personnel change, specifically the resignation of the Vice President of the Investment Department. It includes details such as the name, position, reason for change, and effective date. There is no financial data, no mention of reports, no regulatory filings beyond the personnel change, and no other context suggesting a different category. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in senior management.
2026-04-30 Chinese
115年4月變更登記
Share Issue/Capital Change Classification · 95% confidence The document contains detailed information about the company's capital structure, including authorized capital, paid-in capital, and changes in capital such as cash capital increase, capital surplus conversion, earnings conversion, and employee stock option conversion. It is a structured disclosure of capital-related data rather than a narrative report or announcement. The document length is short (812 characters), but it is not merely an announcement of a report publication or a certification. It specifically details capital and share capital changes, which aligns with the category for announcements regarding new share issues or capital changes. Therefore, the document fits best under the 'Share Issue/Capital Change' category.
2026-04-30 Chinese
公司基本資料
Regulatory Filings Classification · 95% confidence The document is a company profile or disclosure form providing detailed company information such as company name, address, contact details, board members, accounting firm, stock information, and other corporate data. It does not contain financial statements, management discussion, or any report content. The length is 2467 characters, which is relatively short and more consistent with a regulatory announcement or company information disclosure rather than a full report. There is no indication of an annual report, interim report, earnings release, or any other specific report type. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2026-04-30 Chinese
公告本公司115年第一季個別財務報告董事會 預計召開日期為115年05月05日
Report Publication Announcement Classification · 85% confidence The document is a brief announcement (552 characters) on the company information site about the planned date of the board meeting to review and approve the Q1 individual financial report. It contains no actual financial numbers or detailed report, only a notice of when the report will be presented to the board. This fits the definition of a Report Publication Announcement (RPA): announcing the timing of a report rather than the report itself.
2026-04-27 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.